From George Adams
Here is some background:
1. Ascend provides a platform to optimize workflow in echocardiography units in a large number of hospitals in North America.
2. The Company announced last year a collaboration with Ascend Cardiovascular (see NR 2023-08-10) and the creation of a prototype integrated product for 3D-scans later in the year.
3. Today, we announced the Company has expanded the relationship to include 2D and 3D studies and that Ascend will help with sales of both 2D and 3D systems.
4. In addition, we have been invited to be part of Ascend’s “next-generation” platform, called Catalyst, which is under development.
5. The more the VMS+ can be seamlessly used by echocardiolographers, the better as the COVID pandemic along with the aging population continues to create more and more patients with heart conditions that need to be assessed and monitored.
Thank you for your interest and support, as the Company continues to improve cardiac diagnostics for everyone, everywhere and especially for children born with heart defects,
Regards,
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
TSXV-VPT